Hematology · USMLE Step 1 and Step 2

Warfarin song

Warfarin - Mechanism & Reversal, as a song. Hear the short teaser here. The full song is on YouTube and Spotify.

Warfarin

Full song on YouTube ↗Spotify ↗

Key points in this song10

Warfarin inhibits Vitamin K epoxide reductase (VKOR), blocking regeneration of reduced Vitamin K, thereby impairing hepatic synthesis of clotting factors II, VII, IX, and X, as well as Protein C and Protein S.
Factor VII has the shortest half-life, making the PT/INR the first to rise after warfarin initiation and the primary monitoring parameter.
Protein C and Protein S are anticoagulant factors also inhibited by warfarin; their rapid depletion early in therapy can cause a transient hypercoagulable state, explaining warfarin-induced skin necrosis (especially in Protein C deficiency).
Warfarin crosses the placenta and is teratogenic (fetal warfarin syndrome: stippled epiphyses, nasal hypoplasia); heparin is the safe anticoagulant alternative in pregnancy.
Cytochrome P450 interactions are high-yield: enzyme inducers (rifampin, carbamazepine, phenytoin) decrease warfarin effect; enzyme inhibitors (fluconazole, amiodarone, metronidazole) increase warfarin effect and bleeding risk.
For supratherapeutic INR without serious bleeding, withholding warfarin ± oral Vitamin K1 (phytonadione) is appropriate; onset of INR correction with oral Vitamin K takes 24–48 hours.
For life-threatening or intracranial bleeding, immediate reversal requires 4-factor Prothrombin Complex Concentrate (4F-PCC) plus IV Vitamin K; fresh frozen plasma (FFP) is an alternative but carries volume overload risk.
Warfarin effect is potentiated by Vitamin K-deficient states (malnutrition, prolonged antibiotic use eliminating gut flora) because less dietary substrate competes with warfarin's mechanism.
Therapeutic INR goal is 2–3 for most indications (DVT/PE, atrial fibrillation, bioprosthetic valves); INR goal is 2.5–3.5 for mechanical mitral valves or recurrent thromboembolism on therapy.
Heparin bridging is used when initiating warfarin for acute thrombosis because warfarin takes 5–7 days to achieve full anticoagulation, and early Protein C/S depletion creates initial hypercoagulability.